Synthetic Genomics - Engineered Bacteriophage Platform's Unit Acquisition

Synthetic Genomics - Engineered Bacteriophage Platform raised a round of funding on March 01, 2018. Investors include C3J Therapeutics.

Synthetic Genomics (SGI) is dedicated to developing and commercializing genomic-driven solutions to address global energy and environment challenges. The company's main research and business programs …

Articles about Synthetic Genomics - Engineered Bacteriophage Platform's Unit Acquisition: